A short and easy-to-digest video aimed at VLU patients and carers. Includes an introduction to VLUs and how they can be treated.
Contact us for full access to share these videos with colleagues.
The Health Information Network (THIN) database contains information on more than 11 million patients from 562 primary care practices across the UK and has been shown to be representative of the UK population in terms of demographics and disease distribution. This real-life study assessed clinical outcomes and cost-effectiveness of three compression systems (3M™ Coban™ 2 Layer Compression System, *UrgoKTwo™ and **Profore™) in treating newly diagnosed VLUs in the UK, from the perspective of the NHS.
Contact us to get an appraisal of potential savings in your facility.
Key findings3
Real world evidence over a 6-month evaluation demonstrates that treating newly-diagnosed VLUs with Coban 2 compared with UrgoKTwo™ and Profore™:
• Affords a more cost-effective use of NHS-funded resources in clinical practice
• Results in an increased healing rate
• Improves ‘health related quality of life’ score
• Reduces NHS management costs
*UrgoKTwo is a trademark of Urgo Ltd
**Profore is a trademark of Smith & Nephew Ltd